All Stories

  1. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients

    Article • Vox Sanguinis, September 2017, Wiley

    Dr Mark Roest

  2. Normal Platelet Activation Profile in Patients with Peripheral Arterial Disease on Aspirin

    Article • Thrombosis Research, March 2015, Elsevier

    Dr Mark Roest

  3. Coagulation activation during air travel is not initiated via the extrinsic pathway

    Article • British Journal of Haematology, December 2014, Wiley

    Dr Mark Roest

  4. Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity

    Article • Journal of Thrombosis and Haemostasis, October 2014, Elsevier

    Dr Mark Roest

  5. Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow

    Article • PLoS ONE, September 2014, PLOS

    Dr Mark Roest

  6. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen

    Article • AIDS, September 2014, Wolters Kluwer Health

    Dr Mark Roest

  7. The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI

    Article • Thrombosis Journal, August 2014, Springer Science + Business Media

    Dr Mark Roest

  8. Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques

    Article • PLoS ONE, August 2014, PLOS

    Dr Mark Roest

  9. Hemocompatibility Assessment of two siRNA Nanocarrier Formulations

    Article • Pharmaceutical Research, May 2014, Springer Science + Business Media

    Dr Mark Roest, Professor Raymond Schiffelers

  10. Platelet‐reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta‐analysis

    Article • Journal of Thrombosis and Haemostasis, May 2014, Elsevier

    Dr Mark Roest

  11. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets

    Article • Cardiovascular Research, April 2014, European Society of Cardiology

    Dr Mark Roest

  12. The Relationship between Fractional Flow Reserve, Platelet Reactivity and Platelet Leukocyte Complexes in Stable Coronary Artery Disease

    Article • PLoS ONE, December 2013, PLOS

    Dr Mark Roest

  13. Renal Ischemia-Reperfusion Induces Release of Angiopoietin-2 From Human Grafts of Living and Deceased Donors

    Article • Transplantation, August 2013, Wolters Kluwer Health

    Dr Mark Roest

  14. Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers

    Article • PLoS ONE, June 2013, PLOS

    Dr Mark Roest

  15. Fibronectin/fibrinogen/tropoelastin on a stent to promote CD34+cell growth does not reduce neointima formation

    Article • Interventional Cardiology, June 2013, OMICS Publishing Group

    Dr Mark Roest

  16. Cardiovascular Disease Risk Factors in Women With a History of Early-Onset Preeclampsia

    Article • Obstetrics and Gynecology, May 2013, Wolters Kluwer Health

    Dr Mark Roest

  17. Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses

    Article • PLoS ONE, April 2013, PLOS

    Dr Mark Roest

  18. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients

    Article • Thrombosis Research, March 2013, Elsevier

    Dr Mark Roest

  19. Platelet Activation Test in Unprocessed Blood (Pac-t-UB) to Monitor Platelet Concentrates and Whole Blood of Thrombocytopenic Patients

    Article • Transfusion Medicine and Hemotherapy, January 2013, Karger Publishers

    Dr Mark Roest

  20. Flow cytometric assessment of agonist‐induced P‐selectin expression as a measure of platelet quality in stored platelet concentrates

    Article • Transfusion, December 2012, Wiley

    Dr Mark Roest, Dr Rutger A Middelburg

  21. Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro

    Article • BMC Nephrology, September 2012, Springer Science + Business Media

    Dr Mark Roest

  22. A fibronectin‐fibrinogen‐tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function

    Article • Journal of Cellular and Molecular Medicine, August 2012, Wiley

    Dr Mark Roest

  23. Measurement of platelet responsiveness using antibody-coated magnetic beads for lab-on-a-chip applications

    Article • Platelets, February 2012, Taylor & Francis

    Dr Mark Roest

  24. The platelet P2Y12receptor contributes to granule secretion through Ephrin A4 receptor

    Article • Platelets, January 2012, Taylor & Francis

    Dr Mark Roest

  25. Platelet Interaction with the Vessel Wall

    Article • January 2012, Springer Science + Business Media

    Dr Mark Roest

  26. Real-Time Activation of Blood Platelets Studied with Magnetic Microparticles

    Article • Biophysical Journal, January 2012, Elsevier

    Dr Mark Roest

  27. Measurement of Platelet Activation with Anti-P-Selectin Coated Magnetic Microparticles

    Article • Biophysical Journal, February 2011, Elsevier

    Dr Mark Roest

  28. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds

    Article • Molecular BioSystems, January 2011, Royal Society of Chemistry

    Dr Mark Roest

  29. Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy

    Article • British Journal of Haematology, October 2010, Wiley

    Dr Mark Roest

  30. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study

    Article • The Lancet Neurology, November 2009, Elsevier

    Dr Mark Roest

  31. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women

    Article • Atherosclerosis, August 2008, Elsevier

    Dr Mark Roest

  32. High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women

    Article • Journal of Clinical Lipidology, August 2008, Elsevier

    Dr Mark Roest

  33. Paraoxonase (PON1) is associated with familial combined hyperlipidemia

    Article • Atherosclerosis, July 2008, Elsevier

    Dr Mark Roest

  34. Maternal TLR4 and NOD2 Gene Variants, Pro-Inflammatory Phenotype and Susceptibility to Early-Onset Preeclampsia and HELLP Syndrome

    Article • PLoS ONE, April 2008, PLOS

    Dr Mark Roest

  35. 18: Classic risk factors predictive of first cardiovascular events in women with a history of early-onset preeclampsia: Opportunities for primary prevention

    Article • American Journal of Obstetrics and Gynecology, December 2007, Elsevier

    Dr Mark Roest

  36. Analysis of case-cohort data: A comparison of different methods

    Article • Journal of Clinical Epidemiology, April 2007, Elsevier

    Dr Mark Roest

  37. High-throughput genotyping with infrared fluorescence allele specific hybridization (iFLASH): A simple, reliable and low-cost alternative

    Article • Clinical Biochemistry, July 2006, Elsevier

    Dr Mark Roest

  38. Paraoxonase genotype and carotid intima???media thickness in children with familial hypercholesterolemia

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, June 2006, Oxford University Press (OUP)

    Dr Mark Roest, Dr Albert Wiegman

  39. A Randomized, Masked, Cross-over Trial of Lisinopril for Inflammatory Macular Edema

    Article • American Journal of Ophthalmology, April 2006, Elsevier

    Dr Mark Roest

  40. HFE genotypes and dietary heme iron: No evidence of strong gene–nutrient interaction on serum ferritin concentrations in middle-aged women

    Article • Nutrition Metabolism and Cardiovascular Diseases, January 2006, Elsevier

    Dr Mark Roest

  41. The Estrogen Receptor α Gene and Breast Cancer Risk (The Netherlands)

    Article • Cancer Causes & Control, December 2005, Springer Science + Business Media

    Dr Mark Roest

  42. Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia

    Article • Biochemical and Biophysical Research Communications, August 2005, Elsevier

    Dr Mark Roest

  43. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands)

    Article • Cancer Causes & Control, August 2005, Springer Science + Business Media

    Dr Mark Roest

  44. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia

    Article • Clinical Biochemistry, February 2005, Elsevier

    Dr Mark Roest

  45. Trace microalbuminuria in inflammatory cystoid macular edema

    Article • American Journal of Ophthalmology, December 2004, Elsevier

    Dr Mark Roest

  46. Single step high-throughput determination of Toll-like receptor 4 polymorphisms

    Article • Journal of Immunological Methods, June 2004, Elsevier

    Dr Mark Roest

  47. Paraoxonase Genotype, LDL-oxidation and Carotid Atherosclerosis in Male Life-long Smokers

    Article • Free Radical Research, June 2004, Taylor & Francis

    Dr Mark Roest

  48. Factor V Leiden mutation accelerates the onset of natural menopause

    Article • Menopause, September 2003, Wolters Kluwer Health

    Dr Mark Roest

  49. Factor V Leiden in central venous catheter‐associated thrombosis

    Article • British Journal of Haematology, July 2002, Wiley

    Dr Mark Roest

  50. Quality and Quantity of DNA Isolated from Frozen Urine in Population-Based Research

    Article • Analytical Biochemistry, May 2002, Elsevier

    Dr Mark Roest